SRC
SSKN

Shufro Rose & Co’s Strata Skin Sciences SSKN Stock Holding History

Shufro Rose & Co’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20
Closed -$3K – 270
2014
Q2 		$3K Hold
20
– – ﹤0.01% 261
2014
Q1 		$6K Buy
+20
New +$7.04K ﹤0.01% 260

Other funds holding SSKN

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TH
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Shufro Rose & Co's SSKN Position: Q3 2014 in Review

Shufro Rose & Co sold out of Strata Skin Sciences (SSKN) in Q3 2014, closing a stake of 20 shares — an estimated $3K sold.

Shufro Rose & Co first reported a position in SSKN in Q1 2014 and held it in 2 quarters. The position peaked at $6K in Q1 2014. 22 funds tracked by Wall St. Rank hold SSKN as of Q3 2014.

  • Shufro Rose & Co reported no remaining Strata Skin Sciences position as of Q3 2014 after selling out during the quarter.
  • Shufro Rose & Co sold 20 Strata Skin Sciences shares in Q3 2014, an estimated $3K.
  • Shufro Rose & Co first reported a position in Strata Skin Sciences in Q1 2014 and held it in 2 quarters.
  • Shufro Rose & Co's Strata Skin Sciences position peaked at $6K in Q1 2014.
  • 22 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q3 2014.

Based on Shufro Rose & Co's 13F filing for Q3 2014, filed 14 Oct 2014.